Qulipta
Drug timelines are a Plus or Pro feature.
18 regulatory and trial events tracked for Qulipta, covering 2021-09-28 to 2026-04-14. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years [Phase 3]